x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




UCB challenges Teva generic drug application

03-07-2013

Belgian pharmaceutical company UCB SA has sued drug-maker Teva Pharmaceutical Industries to stop it manufacturing a generic version of epilepsy drug Vimpat.


ucb, teva, anda, vimpat, lacosamide

WIPR

Payment types accepted